☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Theravance Biopharma
Theravance Biopharma Reports Results of Ampreloxetine in P-III (Study 0170) Study for Symptomatic Neurogenic Orthostatic Hypotensi...
April 6, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.